| EVAMPLIX (BALSTILIMAB) Agenus Inc.
90836060 19 Jul 2021 | on 01 May 2023 | pharmaceutical, therapeutic and biopharmaceutical agents for the treat... Class 005 Class 005 Pharmaceutical Products "BALSTILIMAB" | | | PHOSPHOSYNVAX Agenus Inc.
88518917 17 Jul 2019 | on 13 Feb 2023 | Pharmaceutical and biopharmaceutical agents, namely, vaccines, immunot... Class 005 Class 005 Pharmaceutical Products Pharmaceutical and biopharmaceutical agents, namely, vaccines, immunotherapeutics, and other therapeutic agents, for the prevention and treatment of human diseases, namely, cancers, autoimmune disorders, infectious disease, transplant rejection, and inflammatory disease | | | EVAMPLIX Agenus Inc.
88260718 14 Jan 2019 | on 05 Dec 2022 | Pharmaceutical, therapeutic and biopharmaceutical agents for the treat... Class 005 Class 005 Pharmaceutical Products The word(s) "EVAMPLIX" has no meaning in a foreign language. | | | AXHAZA Agenus Inc.
88260701 14 Jan 2019 | on 05 Dec 2022 | Pharmaceutical, therapeutic and biopharmaceutical agents for the treat... Class 005 Class 005 Pharmaceutical Products The word(s) "AXHAZA" has no meaning in a foreign language. | | | IKAZEE Agenus Inc.
88260647 14 Jan 2019 | on 05 Dec 2022 | Pharmaceutical, therapeutic and biopharmaceutical agents for the treat... Class 005 Class 005 Pharmaceutical Products The word(s) "IKAZEE" has no meaning in a foreign language. | | | ZALIHANCE Agenus Inc.
88260664 14 Jan 2019 | on 05 Dec 2022 | Pharmaceutical, therapeutic and biopharmaceutical agents for the treat... Class 005 Class 005 Pharmaceutical Products The word(s) "ZALIHANCE" has no meaning in a foreign language. | | | AGENTUS Agenus Inc.
90608923 29 Mar 2021 | on 12 Sep 2022 | Cells for medical or clinical use; pharmaceutical and biopharmaceutica... Class 005 Class 005 Pharmaceutical Products Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease Class 042 Class 042 Computer & Software Services & Scientific Services Pharmaceutical, medical, scientific, and biopharmaceutical research and development | | | ONCOPHAGE AGENUS INC.
75435970 18 Feb 1998 | on 05 Nov 2021 | VACCINES FOR THE PREVENTION AND TREATMENT OF CANCER,VACCINES FOR THE P... Class 005 Class 005 Pharmaceutical Products VACCINES FOR THE PREVENTION AND TREATMENT OF CANCER | | | AGENTUS Agenus Inc.
87502704 23 Jun 2017 | on 03 May 2021 | Cells for medical or clinical use; pharmaceutical and biopharmaceutica... Class 005 Class 005 Pharmaceutical Products Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease Class 042 Class 042 Computer & Software Services & Scientific Services Pharmaceutical, medical, scientific, and biopharmaceutical research and development | | | AGENUS Agenus Inc.
86863464 31 Dec 2015 | on 24 Jun 2020 | (Based on Use in Commerce) manufacturing of pharmaceutical and biophar... Class 005 Class 005 Pharmaceutical Products (Based on Use in Commerce) manufacturing of pharmaceutical and biopharmaceutical agents and preparations to the order and specifications of others Class 040 Class 040 Treatment & Processing of Materials Services The mark consists of the stylized word "AGENUS". Class 042 Computer & Software Services & Scientific Services (Based on Intent to Use) vaccines; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease, pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease | | 
